Stella Diagnostics Inc.
SLDX · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $11 | $2 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $11 | $2 | $5 |
| Operating Income | -$1 | -$11 | -$2 | -$5 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | $6 | -$3 | -$12 |
| Pre-Tax Income | -$1 | -$6 | -$6 | -$17 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$6 | -$6 | -$17 |
| % Margin | – | – | – | – |
| EPS | -0.003 | -0.019 | -0.034 | -0.17 |
| % Growth | 83.7% | 44.4% | 79.9% | – |
| EPS Diluted | -0.003 | -0.019 | -0.034 | -0.17 |
| Weighted Avg Shares Out | 402 | 300 | 165 | 96 |
| Weighted Avg Shares Out Dil | 402 | 300 | 165 | 96 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$6 | -$5 | -$16 |
| % Margin | – | – | – | – |